Sulfonamide‐incorporated bis(α‐aminophosphonates) as promising carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and X‐ray crystallographic studies
Archiv der Pharmazie · 2024
DOI: 10.1002/ardp.202400038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Marjan Sobati und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry and Chemical Technology, Faculty of Natural Sciences and Technology, Riga Technical University, Riga, Latvia. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Sulfonamides, Drug Design, Carbonic Anhydrases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
A novel series of sulfonamide‐incorporated bis(α‐aminophosphonates) acting as effective carbonic anhydrase (CA, EC 4.2.1.1) inhibitors is reported. The synthesized bivalent ligands were tested against five human (h) isoforms, hCA I, hCA II, hCA VII, hCA IX, and hCA XIII. Such derivatives showed high activity and selectivity against the cancer‐related, membrane‐bound isoform hCA IX, and among them, compound 5h , tetraisopropyl (1,3‐phenylenebis{[(4‐sulfamoylphenyl)amino]methylene})bis(phosphonate) showed a K I of 15.1 nM, being highly selective against this isoform over all other investigated ones (hCA I/IX = 42; hCA II/IX = 6, hCA VII/IX = 3, hCA XIII/IX = 5). Therefore, compound 5h could be a potential lead for the development of selective anticancer agents. The newly developed sulfonamides were also found effective inhibitors against the cytosolic hCA XIII isoform. Compound 5i displayed the best inhibition against this isoform with a K I of 17.2 nM, equal to that of the well‐known inhibitor acetazolamide (AAZ), but significantly more selective over all other tested isoforms (hCA I/XIII = 239; hCA II/XIII = 23, hCA VII/XIII = 2, hCA IX/XIII = 3) compared to AAZ.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemistry and Chemical Technology, Faculty of Natural Sciences and Technology, Riga Technical University, Riga, Latvia.
- Neurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Florence, Italy.
- Dipartimento di Chimica "Ugo Schiff", University of Florence, Florence, Italy.
- Latvian Institute of Organic Synthesis, Riga, Latvia.
Förderung
- None
Zitieren
APA
Sobati, M., Abdoli, M., Angeli, A., Bonardi, A., Ferraroni, M., Supuran, C. T., & Žalubovskis, R. (2024). Sulfonamide‐incorporated bis(α‐aminophosphonates) as promising carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and X‐ray crystallographic studies. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400038
Vancouver
Sobati M, Abdoli M, Angeli A, Bonardi A, Ferraroni M, Supuran CT, et al. Sulfonamide‐incorporated bis(α‐aminophosphonates) as promising carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and X‐ray crystallographic studies. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400038
BibTeX
@article{Sobati2024,
author = {Sobati, Marjan and Abdoli, Morteza and Angeli, Andrea and Bonardi, Alessandro and Ferraroni, Marta and Supuran, Claudiu T and Žalubovskis, Raivis},
title = {Sulfonamide‐incorporated bis(α‐aminophosphonates) as promising carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and X‐ray crystallographic studies},
journal = {Archiv der Pharmazie},
year = {2024},
doi = {10.1002/ardp.202400038}
}
EUVIMED